Anna Mainka | Antimicrobial Resistance | Innovative Research Award | 2229

Published on by Global Diseases Research

Innovative Research Award

Anna Mainka
Silesian University of Technology, Poland
Innovative Research Award
Affiliation Silesian University of Technology
Country Poland
Scopus ID 57062991800
Documents 40
Citations 901
h-index 19
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0002-2499-1764

Anna Mainka is a researcher affiliated with Silesian University of Technology whose published work addresses environmental health, indoor air quality, airborne contaminants, and antimicrobial resistance related studies. Her scholarly profile includes multidisciplinary investigations on environmental exposure and public health assessment through peer-reviewed publications.[1]

Abstract

This academic recognition article summarizes research activities associated with Anna Mainka and her documented publication record. Research output demonstrates continuing work involving environmental exposure assessment, microbial aerosols, indoor environmental quality, and pollution-related health analysis. Existing studies indicate practical relevance in healthcare and public environmental monitoring applications.[2]

Keywords

Antimicrobial resistance, environmental health, indoor air quality, bacterial aerosols, exposure assessment, healthcare environments, atmospheric pollutants, environmental monitoring.

Introduction

Environmental exposure and antimicrobial resistance have become important interdisciplinary research topics. Studies connecting pollutants and microbial behavior contribute to improved understanding of public health conditions and environmental risk assessment. Contemporary investigations increasingly focus on healthcare environments and urban exposure patterns.[3]

Research Profile

Anna Mainka has documented publications and collaborative investigations focused on air quality assessment, exposure science, and microbiological analysis. The researcher profile indicates publication activity across international journals and multidisciplinary research areas with measurable citation performance.[1]

Research Contributions

Research contributions include studies on bacterial aerosols, particulate matter exposure, healthcare environmental quality, and indoor pollution monitoring. Several investigations evaluate pollutant exposure effects and environmental health risks using observational and applied methodologies.[4]

Publications

Published research associated with Anna Mainka demonstrates sustained contributions in environmental and atmospheric science. Research themes include healthcare microbiology, bacterial aerosols, particulate matter exposure, ventilation studies, and environmental quality assessment. Published work reflects collaborative studies across healthcare and environmental contexts with measurable scholarly influence.[5]

Research Impact

Publication metrics and citation indicators suggest continuing scholarly visibility and research engagement. Citation activity and interdisciplinary collaboration demonstrate relevance within environmental health and microbial exposure research communities.[2]

Award Suitability

The documented publication profile and environmental research activity support consideration for academic recognition associated with innovation and applied research impact. Scholarly output aligns with the interdisciplinary objectives commonly considered within research award evaluations.

Conclusion

Available publication records indicate continuing research activity and measurable scholarly contribution within environmental and antimicrobial research domains. The research profile reflects sustained publication productivity and collaboration across scientific disciplines.

References

  1. Kauch, K., Mainka, A., & Brągoszewska, E. (2026). Airborne antibiotic-resistant bacteria—Challenge for healthcare environments. Atmosphere, 17(6).https://doi.org/10.3390/atmos17060617
  2. Mainka, A., & Żak, M. (2022). Synergistic or antagonistic health effects of long and short-term exposure to ambient NO₂ and PM2.5: A review. International Journal of Environmental Research and Public Health, 19(21).https://doi.org/10.3390/ijerph192114079
  3. Mainka, A. (2021). Preschool children health impacts from indoor exposure to PM2.5 and metals. Environment International, 159.https://doi.org/10.1016/j.envint.2021.107062
  4. Brągoszewska, E., & Mainka, A. (2024). Bacterial aerosol in ambient air—A review study. Applied Sciences, 14(18).https://doi.org/10.3390/app14188250
  5. Kozielska, B., Mainka, A., Żak, M., Kaleta, D., & Mucha, W. (2020). Indoor air quality in residential buildings in Upper Silesia, Poland. Building and Environment, 177.https://doi.org/10.1016/j.buildenv.2020.106914

Branko Dujovic | Dermatoncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Researcher Information
Affiliation Military Medical Academy
Country Serbia
Scopus ID 58245030500
Documents 6
Citations 21
h-index 2
Subject Area Dermatoncology
Event Global Diseases Research Awards
ORCID 0009-0009-1497-5777

Branko Dujovic of the Military Medical Academy, Serbia, is recognized for his contributions to medical research, with a particular focus on dermatoncology. The Innovative Research Award highlights his scholarly excellence, scientific integrity, and meaningful impact on advancing clinical science. Through his published research, interdisciplinary collaboration, and commitment to evidence-based medical investigation, he has built a strong academic profile. His work emphasizes improvements in disease diagnosis, evaluation of treatment strategies, and enhancement of patient-centered healthcare outcomes, reflecting a consistent dedication to advancing knowledge and strengthening modern clinical practice in oncology and dermatology-related research.

Abstract

Branko Dujovic is a researcher affiliated with the Military Medical Academy in Serbia whose scholarly activities contribute to the field of dermatoncology. Through peer-reviewed publications, clinical investigations, and collaborative research efforts, he has supported the advancement of scientific understanding related to skin cancer and associated diseases. His academic record, including indexed publications, citations, and international researcher identifiers, demonstrates engagement with contemporary medical science. The Innovative Research Award acknowledges researchers whose work promotes scientific progress, encourages evidence-based practice, and contributes to improving healthcare knowledge through responsible and impactful research activities.[1]

Keywords

Dermatoncology, Clinical Research, Medical Science, Skin Cancer Research, Academic Excellence, Innovative Research Award, Healthcare Innovation, Disease Investigation, Scientific Publications, Global Diseases Research Awards.

Introduction

Dermatoncology represents a specialized area of medicine focused on understanding, diagnosing, and managing skin-related cancers. Researchers working within this discipline contribute valuable evidence supporting clinical decision-making and patient care improvements. Branko Dujovic has participated in research activities that align with these objectives and support ongoing scientific advancement within the medical community.[1]

Research Profile

Affiliated with the Military Medical Academy, Branko Dujovic maintains an academic profile indexed within international scholarly databases. His publication record includes research outputs relevant to dermatoncology and related medical disciplines. The available metrics indicate active participation in scientific communication and engagement with peer-reviewed research environments.[4]

Research Contributions

The research contributions of Branko Dujovic are associated with clinical and scientific investigations addressing disease mechanisms, patient outcomes, and healthcare practices. His studies support the broader body of medical knowledge by providing data-driven insights that may assist clinicians, researchers, and healthcare institutions in understanding dermatological oncology challenges.[2]

Publications

The researcher has produced six indexed documents that collectively contribute to scholarly discussion within his field. These publications demonstrate participation in scientific dissemination and provide evidence of sustained academic activity. Published work remains an important indicator of research productivity, professional collaboration, and contribution to medical literature.

Research Impact

Citation metrics indicate that the researcher’s publications have been referenced by other scholars, reflecting engagement within the scientific community. While quantitative indicators provide only one measure of influence, citations and indexing demonstrate the visibility of research outputs and their relevance to ongoing academic discussions.[1]

Award Suitability

Branko Dujovic demonstrates characteristics associated with the objectives of the Innovative Research Award, including scholarly productivity, scientific engagement, and commitment to advancing medical knowledge. His documented research activities, institutional affiliation, and contributions to dermatoncology support consideration for recognition within the Global Diseases Research Awards program.[3]

Conclusion

The academic profile of Branko Dujovic reflects participation in meaningful scientific research within dermatoncology. Through publications, citation impact, and professional engagement, he contributes to the advancement of healthcare knowledge. Recognition through the Innovative Research Award highlights the value of continued research efforts that support evidence-based medicine and scientific progress.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Branko Dujovic, Author ID 58245030500. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=58245030500
  2. ORCID. (n.d.). Researcher profile and scholarly identifier for Branko Dujovic
    .    https://orcid.org/0009-0009-1497-5777
  3. Global Diseases Research Awards. (n.d.). Innovative Research Award and recognition framework.
    https://globaldiseases.org/
  4. Dujovic, B., Popovic, A., Jalovcic Suljevic, A., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Bicakcic Filipovic, E., & Kandolf, L. (2026). Prognostic significance of inflammatory biomarkers in first-line immunotherapy for metastatic melanoma: Multicentric study (Version 1). Preprints.org.
    https://doi.org/10.20944/preprints202604.1631.v1
  5. Torres-Zurita, A., Vázquez-Montero, L., Gallego-López, L., Mediano-Rambla, M. D., & de la Cruz-Merino, L. (2023). Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: A case report. Frontiers in Immunology, 14, 1150128.
    https://doi.org/10.3389/fimmu.2023.1150128